- HOME
- 연구현황
- 연구활동
연구활동
| 소속 | 주요저자 | 학술지명 | 논문제목 | IF |
|---|---|---|---|---|
| 정형외과 | ** 여의동 | Journal of Foot & Ankle Surgery | Evaluation of Contact Area and Pressure After Malreduction in Isolated Medial Malleolar Fractures With 2 mm of Displacement: A Cadaveric Study, 2023 Sep-Oct;62(5):774-778 | 1.3 |
| 약제실 | * 송슬기 | Age and Ageing | Effects of defoliant exposure and medication use on the development of Parkinson's disease in veterans, 2023 Oct 2;52(10):afad192 | 6.7 |
| 방사선종양학과 | * 박소연 | Plos one | Quantitative radiomics approach to assess acute radiation dermatitis in breast cancer patients, 2023 Oct 26;18(10):e0293071 | 3.7 |
| 호흡기내과 | * 강혜린, 송진화, 정근범, 이병준 | Translational lung cancer research | Impact of lung cancer screening with low-dose chest computed tomography on an older population: a retrospective cohort study, 2023 Oct 31;12(10):2068-2082 | 4 |
| 호흡기내과 | *노형준, **강혜린, 송진화, 함신영, 박연경, 원하경, 정근범, 김춘관, 안영미, 이병준 | Medicine | Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study, 2023 Nov 10;102(45):e35987 | 1.6 |
| 호흡기내과 | 원하경 | Lung | Baseline Cohort Profile of the Korean Chronic Cough Registry: A Multicenter, Prospective, Observational Study, 2023 Oct;201(5):477-488 | 5 |
| 감염내과 | *함신영 | Journal of Korean medical science | Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients, 2023 Sep 4;38(35):e272 | 4.5 |
| 혈액종양내과 | *함아롱, **임태규, 김해수, 이영 | Cancers | Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer, 2023 Aug 21;15(16):4198 | 5.2 |
| 내분비내과 | *이지현, *김예안, **서제현, 김영식, 이영 | Nutrients | Association between Vitamin D Deficiency and Clinical Parameters in Men and Women Aged 50 Years or Older: A Cross-Sectional Cohort Study, 2023 Jul 5;15(13):3043 | 5.9 |
| 호흡기내과 | **박연경 | Journal of Personalized Medicine | The Influence of Cardiac Arrest Floor-Level Location within a Building on Survival Outcomes, 2023 Aug 16;13(8):1265 | 3.4 |
* 제1저자, ** 교신저자
